Acord cadru furnizare medicamente program ONCOLOGIE,HEMOFILIE, ENDOCRINE, DIABET, HIV/SIDA, MALNUTRITIE
6 suppliers awarded•172 lots awarded•€1.06M awarded
Buyer: Spitalul Judetan de Urgenta "Mavromati" Botosani / Botosani, Romania
Awarded value
€1.06M
Estimated value
€1.06M
Awarded at 100% of estimated value
Award date
—
Winners
6
Lots awarded
172
Award values
Notice total
€1.06M
Sum of lot awards
€29.39M
TED notice total and lot-level values do not exactly match.
Winners
Bucuresti, ROU
€599,221 This contract
580 award notices•1,967 awarded lots•€329.70M total
Bucuresti, ROU
€517,341 This contract
68 award notices•108 awarded lots•€17.89M total
Bucuresti, ROU
€129,603 This contract
737 award notices•2,493 awarded lots•€436.65M total
Bucuresti, ROU
€69,230 This contract
76 award notices•78 awarded lots•€31.92M total
Mogosoaia, ROU
€41,045 This contract
632 award notices•2,953 awarded lots•€145.47M total
Bucuresti, ROU
€4,152 This contract
89 award notices•168 awarded lots•€146.34M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0093 | Framework | Not specified | €2.7M | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0151 | Framework | Not specified | €1.9M | Antivirals for systemic use (33651400) |
| LOT-0145 | Framework | Not specified | €1.9M | Antivirals for systemic use (33651400) |
| LOT-0095 | Framework | Not specified | €1.5M | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0135 | Framework | Not specified | €1.1M | Insulin (33615100) |
| LOT-0054 | Framework | Not specified | €1.1M | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0131 | Framework | Not specified | €977,423 | Insulin (33615100) |
| LOT-0134 | Framework | Not specified | €949,284 | Insulin (33615100) |
| LOT-0139 | Framework | Not specified | €746,124 | Antivirals for systemic use (33651400) |
| LOT-0030 | Framework | Not specified | €688,420 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0159 | Framework | Not specified | €589,478 | Antivirals for systemic use (33651400) |
| LOT-0164 | Framework | Not specified | €569,005 | Antivirals for systemic use (33651400) |
| LOT-0004 | Framework | Not specified | €556,759 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0050 | Framework | Not specified | €519,778 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0003 | Framework | PFIZER ROMANIA | €517,341 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0069 | Framework | Not specified | €505,441 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0090 | Framework | Not specified | €505,099 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0042 | Framework | Not specified | €492,864 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0082 | Framework | Not specified | €431,960 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0084 | Framework | Not specified | €416,746 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0154 | Framework | Not specified | €412,066 | Antivirals for systemic use (33651400) |
| LOT-0124 | Framework | FARMEXIM S.A. | €392,013 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0144 | Framework | Not specified | €386,948 | Antivirals for systemic use (33651400) |
| LOT-0060 | Framework | Not specified | €360,172 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0128 | Framework | Not specified | €350,037 | Medicinal products for the musculo-skeletal system (33632000) |
| LOT-0009 | Framework | Not specified | €328,510 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0080 | Framework | Not specified | €328,452 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0116 | Framework | Not specified | €316,427 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0036 | Framework | Not specified | €260,173 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0094 | Framework | Not specified | €253,794 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0152 | Framework | Not specified | €251,723 | Antivirals for systemic use (33651400) |
| LOT-0109 | Framework | Not specified | €225,978 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0006 | Framework | Not specified | €216,658 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0132 | Framework | Not specified | €207,985 | Insulin (33615100) |
| LOT-0123 | Framework | FARMEXIM S.A. | €198,659 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0142 | Framework | Not specified | €194,391 | Antivirals for systemic use (33651400) |
| LOT-0031 | Framework | Not specified | €192,721 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0055 | Framework | Not specified | €189,872 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0096 | Framework | Not specified | €189,313 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0028 | Framework | Not specified | €188,353 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0101 | Framework | Not specified | €185,109 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0025 | Framework | Not specified | €185,023 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0052 | Framework | Not specified | €183,786 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0002 | Framework | Not specified | €153,349 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0070 | Framework | Not specified | €152,088 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0108 | Framework | Not specified | €149,623 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0166 | Framework | Not specified | €147,843 | Antivirals for systemic use (33651400) |
| LOT-0118 | Framework | Not specified | €142,673 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0133 | Framework | Not specified | €139,413 | Insulin (33615100) |
| LOT-0032 | Framework | ALLIANCE HEALTHCARE ROMÂNIA SRL | €129,603 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0020 | Framework | Not specified | €128,570 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0045 | Framework | Not specified | €126,494 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0129 | Framework | Not specified | €126,394 | Medicinal products for the musculo-skeletal system (33632000) |
| LOT-0130 | Framework | Not specified | €122,259 | Medicinal products for the musculo-skeletal system (33632000) |
| LOT-0099 | Framework | Not specified | €116,473 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0106 | Framework | Not specified | €109,666 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0066 | Framework | Not specified | €109,150 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0038 | Framework | Not specified | €106,048 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0115 | Framework | Not specified | €101,910 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0046 | Framework | Not specified | €101,726 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0047 | Framework | Not specified | €98,321 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0111 | Framework | Not specified | €92,950 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0079 | Framework | Not specified | €91,019 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0160 | Framework | Not specified | €87,446 | Antivirals for systemic use (33651400) |
| LOT-0146 | Framework | Not specified | €84,432 | Antivirals for systemic use (33651400) |
| LOT-0103 | Framework | Not specified | €76,319 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0065 | Framework | Not specified | €76,052 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0091 | Framework | Not specified | €74,142 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0061 | Framework | SERMEDIC S.R.L. | €69,230 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0141 | Framework | Not specified | €67,175 | Antivirals for systemic use (33651400) |
| LOT-0007 | Framework | Not specified | €59,930 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0088 | Framework | Not specified | €59,302 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0104 | Framework | Not specified | €58,936 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0049 | Framework | Not specified | €50,796 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0068 | Framework | Not specified | €48,129 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0107 | Framework | Not specified | €48,004 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0089 | Framework | Not specified | €46,005 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0067 | Framework | Not specified | €43,504 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0062 | Framework | MEDIPLUS EXIM | €41,045 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0064 | Framework | Not specified | €41,045 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0157 | Framework | Not specified | €40,283 | Antivirals for systemic use (33651400) |
| LOT-0037 | Framework | Not specified | €39,191 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0005 | Framework | Not specified | €38,778 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0014 | Framework | Not specified | €36,713 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0075 | Framework | Not specified | €34,825 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0073 | Framework | Not specified | €34,244 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0083 | Framework | Not specified | €33,829 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0035 | Framework | Not specified | €33,331 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0149 | Framework | Not specified | €32,785 | Antivirals for systemic use (33651400) |
| LOT-0086 | Framework | Not specified | €31,714 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0156 | Framework | Not specified | €29,354 | Antivirals for systemic use (33651400) |
| LOT-0001 | Framework | Not specified | €28,080 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0027 | Framework | Not specified | €27,599 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0015 | Framework | Not specified | €26,738 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0017 | Framework | Not specified | €26,504 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0029 | Framework | Not specified | €26,292 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0059 | Framework | Not specified | €25,955 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0016 | Framework | Not specified | €25,944 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0087 | Framework | Not specified | €23,253 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0163 | Framework | Not specified | €22,142 | Antivirals for systemic use (33651400) |
| LOT-0092 | Framework | Not specified | €21,672 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0147 | Framework | Not specified | €21,452 | Antivirals for systemic use (33651400) |
| LOT-0010 | Framework | Not specified | €21,061 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0136 | Framework | Not specified | €20,627 | Antivirals for systemic use (33651400) |
| LOT-0113 | Framework | Not specified | €20,145 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0077 | Framework | Not specified | €19,060 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0074 | Framework | Not specified | €18,040 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0026 | Framework | Not specified | €17,739 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0034 | Framework | Not specified | €16,672 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0140 | Framework | Not specified | €15,443 | Antivirals for systemic use (33651400) |
| LOT-0021 | Framework | Not specified | €15,412 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0162 | Framework | Not specified | €15,243 | Antivirals for systemic use (33651400) |
| LOT-0018 | Framework | Not specified | €14,549 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0013 | Framework | Not specified | €14,427 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0040 | Framework | Not specified | €14,024 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0011 | Framework | Not specified | €13,927 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0053 | Framework | Not specified | €13,038 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0048 | Framework | Not specified | €12,995 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0057 | Framework | Not specified | €12,950 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0165 | Framework | Not specified | €12,720 | Antivirals for systemic use (33651400) |
| LOT-0019 | Framework | Not specified | €12,548 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0110 | Framework | Not specified | €11,394 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0041 | Framework | Not specified | €11,345 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0072 | Framework | Not specified | €10,709 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0112 | Framework | Not specified | €10,077 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0051 | Framework | Not specified | €9,643 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0008 | Framework | Not specified | €9,444 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0102 | Framework | Not specified | €9,222 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0039 | Framework | Not specified | €9,108 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0023 | Framework | Not specified | €9,092 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0097 | Framework | Not specified | €8,978 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0126 | Framework | FARMEXIM S.A. | €8,549 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0155 | Framework | Not specified | €8,518 | Antivirals for systemic use (33651400) |
| LOT-0033 | Framework | Not specified | €8,342 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0114 | Framework | Not specified | €8,242 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0117 | Framework | Not specified | €8,008 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0122 | Framework | Not specified | €7,640 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0098 | Framework | Not specified | €7,080 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0024 | Framework | Not specified | €7,052 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0158 | Framework | Not specified | €6,329 | Antivirals for systemic use (33651400) |
| LOT-0022 | Framework | Not specified | €6,245 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0138 | Framework | Not specified | €5,500 | Antivirals for systemic use (33651400) |
| LOT-0121 | Framework | Not specified | €4,826 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0076 | Framework | Not specified | €4,688 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0043 | Framework | Not specified | €4,546 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0125 | Framework | Not specified | €4,469 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0100 | Framework | Not specified | €4,311 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0153 | Framework | Romastru Trading | €4,152 | Antivirals for systemic use (33651400) |
| LOT-0085 | Framework | Not specified | €4,106 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0137 | Framework | Not specified | €3,988 | Antivirals for systemic use (33651400) |
| LOT-0058 | Framework | Not specified | €3,104 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0161 | Framework | Not specified | €3,019 | Antivirals for systemic use (33651400) |
| LOT-0150 | Framework | Not specified | €2,979 | Antivirals for systemic use (33651400) |
| LOT-0012 | Framework | Not specified | €2,818 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0044 | Framework | Not specified | €2,657 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0071 | Framework | Not specified | €2,647 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0119 | Framework | Not specified | €2,231 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0127 | Framework | Not specified | €1,897 | Medicinal products for the musculo-skeletal system (33632000) |
| LOT-0056 | Framework | Not specified | €1,753 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0105 | Framework | Not specified | €1,098 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0078 | Framework | Not specified | €1,051 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0081 | Framework | Not specified | €967 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0120 | Framework | Not specified | €829 | Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0063 | Framework | Not specified | €621 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0148 | Framework | Not specified | €535 | Antivirals for systemic use (33651400) |
| LOT-0143 | Framework | Not specified | €357 | Antivirals for systemic use (33651400) |
| LOT-0167 | Framework | Not specified | — | Antivirals for systemic use (33651400) |
| LOT-0168 | Framework | Not specified | — | Antivirals for systemic use (33651400) |
| LOT-0169 | Framework | Not specified | — | Antivirals for systemic use (33651400) |
| LOT-0170 | Framework | Not specified | — | Antivirals for systemic use (33651400) |
| LOT-0171 | Framework | Not specified | — | Milk powder (15511700) |
| LOT-0172 | Framework | Not specified | — | Milk powder (15511700) |